Importance Pituitary adenomas are neoplasms of the pituitary adenohypophyseal cell
lineage and include functioning tumors, characterized by the secretion of pituitary hormones …

Growth hormone-secreting pituitary adenomas that cause acromegaly arise as monoclonal
expansions of differentiated somatotroph cells and are usually sporadic. They are almost …

Abstract Purpose The 14th Acromegaly Consensus Conference was convened to consider
biochemical criteria for acromegaly diagnosis and evaluation of therapeutic efficacy …

Recurrence and biochemical remission rates vary widely among different histological
subtypes of pituitary adenoma. In this prospective study, we evaluated 107 consecutive …

Purpose Biochemical control is the main determinant of survival, clinical manifestations and
comorbidities in acromegaly. Transsphenoidal selective adenomectomy (TSA) is the initial …

Purpose The aim of this systematic review is to evaluate the long-term endocrine outcomes
and postoperative complications following endoscopic vs. microscopic transsphenoidal …

Context The development of diabetes insipidus (DI) following transsphenoidal resection of
pituitary adenomas has been associated with higher postsurgical morbidity and longer …

Objective To describe the treatment and long-term outcomes of patients with acromegaly
from all healthcare regions in Sweden. Design and methods Analysis of prospectively …

Acromegaly is a rare and challenging disease calling for management in highly specialised
multidisciplinary teams (MDTs). Untreated disease has severe morbidity and a clearly …

Acromegaly is a rare disease with prevalence of approximately 60 cases per million, slight
female predominance and peak onset in adults in the fourth decade. Clinical diagnosis is …